INGREZZA Trademark

Trademark Overview

On Tuesday, December 15, 2015, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 86850086. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 18, 2023. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological and psychiatric diseases and disorders, tardive dyskinesia, [ Tourette syndrome, ] dystonia, movement disorders, and tics
ingrezza

General Information

Serial Number86850086
Word MarkINGREZZA
Filing DateTuesday, December 15, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 18, 2023
Registration Number5192213
Registration DateTuesday, April 25, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological and psychiatric diseases and disorders, tardive dyskinesia, [ Tourette syndrome, ] dystonia, movement disorders, and tics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 21, 2015
Primary Code005
First Use Anywhere DateWednesday, February 1, 2017
First Use In Commerce DateWednesday, February 1, 2017

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 18, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 18, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 21, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, April 25, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 23, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 23, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 20, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 27, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 9, 2017USE AMENDMENT FILED
Monday, February 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 9, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, January 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2017SOU EXTENSION 1 GRANTED
Monday, January 23, 2017SOU EXTENSION 1 FILED
Monday, January 23, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 25, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 13, 2016ASSIGNED TO LIE
Saturday, March 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 25, 2016EXAMINER'S AMENDMENT ENTERED
Friday, March 25, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2016EXAMINERS AMENDMENT E-MAILED
Friday, March 25, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 17, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2016NON-FINAL ACTION WRITTEN
Wednesday, February 10, 2016ASSIGNED TO EXAMINER
Monday, December 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 18, 2015NEW APPLICATION ENTERED

Related Keywords

ingrezza disorders syndrome tourette dystonia movement tics dyskinesia tardive neurological treatment